Please click on the study below to read the IBC (Institutional Biosafety Committee) minutes for our approved trials.
Date: May 5, 2026
Title: PBI-AMD-002: A Phase 1/2a Study of VOY-101 in Subjects with Advanced Non-Neovascular Age-Related Macular Degeneration (JOURNEY)
Click here to access
Date: April 7, 2026
Title: A Phase 1/2, study to evaluate the safety, tolerability, and efficacy of one-time intravitreal dose of SAR446597 in participants with geographic atrophy secondary to age-related macular degeneration
Click here to access
